EKF Diagnostics, the global in vitro diagnostics company, announces that a recent study has confirmed that its Quo-Test® A1c point-of-care testing (POCT) analyzer shows comparable performance to a lab ...

The global point-of-care testing (POCT) market is driven by rising patient demand, technological innovation, and supportive regulatory frameworks. Rapid diagnostics, enhanced chronic disease ...

LumiraDx shares these and other findings from its second annual U.S. survey “Point of Care Diagnostics: A Clinician's View” WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: ...

In clinical settings, point-of-care testing (POCT) provides rapid diagnostic information to help make clinical decisions as early as possible in the care and treatment of patients. Ensuring that such ...

Dublin, Jan. 19, 2024 (GLOBE NEWSWIRE) -- The "Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles" report has been added to ResearchAndMarkets ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Point-of-Care Testing (POCT) Market - Trends and Forecast To 2024" report to their offering. The Global Point-of ...

Large scale deployment of rapid, low-cost, hand-held point of care testing devices for diagnosing infectious diseases is critical for improving global health. Recent advances in engineering and ...

This research report titled ‘ POCT Market in the US 2015-2019 ’, provides an in-depth analysis of market growth in terms of revenue and emerging market trends. This market research report also ...

Objectives The common cold is the main cause of medical time loss in elite sport. Rapid diagnosis has been a challenge that may be amenable to molecular point-of-care testing (POCT). Methods We ...